GTC Biotherapeutics (fka GTCB)

[keitern]

I prefer a more humble and less presumptuous CEO. I resent Cox's attitude (my interpretation) that GTC will be successful but share price be damned. It is obvious to me that GTC is spending 22M this half yr. not to increase share price but to increase the probability that GTC will continue in some form. They had better sell this company or explain clearly where the next 22M is coming from. Why investors allow this kind of irresponsible spending is beyond me. This company has been underfunded (or overspent) from the start.